Inventor

Philip L. Felgner

Inventor

Rancho Santa Fe, CA, US

Overview

1990–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 49 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes20%

C12NMicroorganisms or enzymes19%

C07KPeptides13%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%

G01NInvestigating or analysing materials by determining their chemical or physical properties8%

Y02ATechnologies for adaptation to climate change6%

C07DHeterocyclic compounds5%

C12YEnzymes5%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%

PatentTitleYear

11,130,994Automated, cloud-based, point-of-care (POC) pathogen and antibody array detection system and method2021 10,260,168Microfluidic devices and methods2019 10,197,577Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines2019 10,174,311Compositions and methods for immunodominant antigens2019 10,053,687Compositions and methods for immunodominant antigens of 2018 9,494,586'Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis '2016 9,297,803'Compositions and methods for immunodominant antigens'2016 9,182,412'Borrelia diagnostics and screening methods'2015 8,883,431'Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis '2014 8,329,418'Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis '2012 8,247,181'Borrelia diagnostics and screening methods'2012 8,114,614'Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis '2012 7,927,818'Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis '2011 7,470,675'Methods for treating cancer using interferon-Ï‰-expressing polynucleotides'2008 7,393,533'H3L envelope protein immunization methods and H3L envelope passive protection methods'2008 7,319,012'Protein arrays and methods and systems for producing the same'2008 7,268,120'Methods for treating cancer using cytokine-expressing polynucleotides'2007 7,250,404'Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response'2007 6,936,470'Rapid and enzymeless cloning of nucleic acid fragments'2005 6,867,195'Lipid-mediated polynucleotide administration to reduce likelihood of subject\'s becoming infected'2005 6,746,868'Chemical modification of DNA using peptide nucleic acid conjugates'2004 6,710,035'Generation of an immune response to a pathogen'2004 6,706,694'Expression of exogenous polynucleotide sequences in a vertebrate'2004 6,673,776'Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human'2004 6,433,017'Amphiphilic polyamine compounds'2002 6,413,942'Methods of delivering a physiologically active polypeptide to a mammal'2002 6,387,395'N-1, (1-1) -dialkyloxy - and N- 1, (1-1) -dialkenyloxy- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor'2002 6,348,499'Amphiphilic polyamide compounds'2002 6,280,977'Method for generating transcriptionally active DNA fragments'2001 6,228,844'Stimulating vascular growth by administration of DNA sequences encoding VEGF'2001 6,214,804'Induction of a protective immune response in a mammal by injecting a DNA sequence'2001 6,165,720'Chemical modification of DNA using peptide nucleic acid conjugates'2000 5,783,179'C-reactive protein fragment with immunomodulatory activity'1998 5,703,055'Generation of antibodies through lipid mediated DNA delivery'1997 5,693,622'Expression of exogenous polynucleotide sequences cardiac muscle of a mammal'1997 5,622,712'N-[.omega., (.omega.-1)-dialkyloxy]- and N-[.omega., (.omega.-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor'1997 5,589,466'Induction of a protective immune response in a mammal by injecting a DNA sequence'1996 5,580,859'Delivery of exogenous DNA sequences in a mammal'1996 5,550,289'N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor'1996 5,545,412'N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor'1996 5,459,127'Cationic lipids for intracellular delivery of biologically active molecules'1995 5,376,369'Vaccine adjuvant'1994 5,366,737'N-[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor'1994 5,264,618'Cationic lipids for intracellular delivery of biologically active molecules'1993 5,208,036'N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor'1993 5,068,198'Liquid single reagent for assays involving confining gels'1991 5,049,386'N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor'1991 4,946,787'N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor'1990 4,897,355'N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–1998Patents assigned to SYNTEX INC (11)· patent assignee history

1990–1997Based in Los Altos, CA, US· patent location history

1993–2008Patents assigned to VICAL INC (15)· patent assignee history

1993–2019Based in Rancho Santa Fe, CA, US· patent location history

1996–2007Patents assigned to WISCONSIN ALUMNI RES FOUND (10)· patent assignee history

1998–2008Based in San Diego, CA, US· patent location history

2002Based in Palo Alto, CA, US· patent location history

2011–2019Patents assigned to FELGNER PHILIP (6)· patent assignee history

2011–2016Patents assigned to GENNARO MARIA LAURA (5)· patent assignee history

2019–2021Based in Irvine, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VICAL INC	15	1993–2008
SYNTEX INC	11	1990–1998
WISCONSIN ALUMNI RES FOUND	10	1996–2007
FELGNER PHILIPself	6	2011–2019
GENNARO MARIA LAURA	5	2011–2016

Locations

Location	Patents	Span
Rancho Santa Fe, California, US	35	1993–2019
Los Altos, California, US	9	1990–1997
Irvine, California, US	2	2019–2021
San Diego, California, US	2	1998–2008
Palo Alto, California, US	1	2002